Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Pricing guide $ = under $0.10 per serving $$ = $0.10$0.20 per serving $$$ = $0.20$0.40 per serving $$$$ = over $0.40 per serving 1
Does GLP-1 Help with Dementia
Tirzepatide: the upgrade Tirzepatide activates two receptors instead of one
Timeline of Regulatory Milestones 2005: Exenatide (Byetta): First GLP-1 agonist approved, twice-daily injections 2010: Liraglutide (Victoza): Longer-lasting, once-daily injection 2014: Dulaglutide (Trulicity): Once-weekly injection arrives 2017: Semaglutide (Ozempic): First once-weekly injection for diabetes with powerful weight-loss effects 2019: Oral semaglutide (Rybelsus): First GLP-1 pill makes it past the stomachs defenses 2021: High-dose semaglutide (Wegovy): FDA approval for obesity treatment 2022: Tirzepatide (Mounjaro): First dual GLP-1/GIP agonist for diabetes 2023: Tirzepatide (Zepbound): Expanded approval for obesity 20232024 : Widespread shortages: Skyrocketing demand for GLP-1s leads to limited availability The shortage that began in late-2023, driven by soaring off-label demand and supply-chain bottlenecks left millions of patients unable to fill even maintenance scripts
For me, the concern is around how this type of rebound effect leads to learned helplessness, a mental state in which a person gets conditioned to believe they cant control or change a situation, so they stop trying even when opportunities for change are available
